Nuvectis Pharma, Inc. (NVCT)
NASDAQ·Healthcare·Biotechnology
$10.72
+2.00%
Mkt Cap $240.54M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$10.00
Range $10.00 – $10.00
Implied Upside
-6.7%
Consensus $10.00 vs current $10.72
NASDAQ·Healthcare·Biotechnology
$10.72
+2.00%
Mkt Cap $240.54M
No recent rating data.
Price Target (1 analysts)
$10.00
Range $10.00 – $10.00
-6.7%
Consensus $10.00 vs current $10.72